全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Assessment of T2-Weighted Coronal Magnetic Resonance Images in the Investigation of Pituitary Lesions

DOI: 10.1155/2014/650926

Full-Text   Cite this paper   Add to My Lib

Abstract:

Magnetic resonance imaging is the most important diagnostic method in the investigation of the pituitary lesions. Our aim is to determine whether T2-weighted coronal images may be helpful in the evaluation of the pituitary gland with suspected pituitary adenomas. One hundred and sixty-seven patients were examined prospectively with T2-weighted coronal and T1-weighted coronal images enhanced with intravenous contrast material. The images were evaluated for the presence, the size, the location, and the ancillary signs including sellar floor erosion or ballooning, infindibulary deviation, convexity of the superior border of the gland, diffuse enlargement of the gland, and the invasion of the cavenous sinuses on both images. In forty-six (28%) patients lesions were revealed on both sequences. In twenty-one (12%) patients the lesions that were revealed on the T1-weighted images were not detected on the T2-weighted images. Positive predictive value, negative predictive value, sensitivity, specificity, and diagnostic accuracy rates of T2-weighted coronal images on the detection of the presence of lesions were 100%, 17.4%, 68.7%, 100%, and 87.4%, respectively. Both T2-weighted coronal and T1-weighted coronal images enhanced with intravenous gadolinium-based contrast material are important in the diagnosis of pituitary adenomas. T2-weighted coronal images could be used as a screening tool for the primary evaluation of the pituitary gland. 1. Introduction Pituitary adenomas are the most common pathologies encountered in the sellar area [1]. They also either may be clinically silent or can cause a variety of symptoms related to compression of adjacent structures and hormone secretion. Today, magnetic resonance (MR) imaging is usually the first diagnostic method in the investigation of pituitary adenomas. The detection of adenomas on MR imaging depends on the image contrast between adenoma and normal pituitary tissue. There are also ancillary signs including sellar floor erosion or ballooning, infindibulary deviation, convexity of the superior border of the gland, diffuse enlargement of the gland, and the invasion of the cavernous sinuses [2]. T1-weighted coronal images enhanced with intravenous gadolinium-based contrast material (IV-GBCM) provide higher detection rates of adenomas. T2-weighted coronal images may be important for the detection of the pituitary adenomas without administration of IV-GBCM. Therefore, time and account of the examinations will be decreased and the cost effectiveness will be increased. Also possible harmful side effects of the IV-GBCM

References

[1]  J.-F. Bonneville, F. Bonneville, and F. Cattin, “Magnetic resonance imaging of pituitary adenomas,” European Radiology, vol. 15, no. 3, pp. 543–548, 2005.
[2]  D. R. Newton, W. P. Dillon, D. Norman, T. H. Newton, and C. B. Wilson, “Gd-DTPA-enhanced MR imaging of pituitary adenomas,” American Journal of Neuroradiology, vol. 10, no. 5, pp. 949–954, 1989.
[3]  M. V. Kulkarni, K. F. Lee, C. B. McArdle, J. W. Yeakley, and F. L. Haar, “1.5-T MR imaging of pituitary microadenomas: technical considerations and CT correlation,” American Journal of Neuroradiology, vol. 9, no. 1, pp. 5–11, 1988.
[4]  S. Chakrabortty, S. Oi, M. Yamaguchi, N. Tamaki, and S. Matsumoto, “Growth hormone-producing pituitary adenomas: MR characteristics and pre- and postoperative evaluation,” Neurologia Medico-Chirurgica, vol. 33, no. 2, pp. 81–85, 1993.
[5]  W. Kucharczyk, J. E. Bishop, D. B. Plewes, M. A. Keller, S. George, and A. D. Elster, “Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging,” American Journal of Roentgenology, vol. 163, no. 3, pp. 671–682, 1994.
[6]  Y. Miki, M. Matsuo, S. Nishizawa et al., “Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging,” Radiology, vol. 177, no. 1, pp. 35–38, 1990.
[7]  P. C. Davis, J. C. Hoffman Jr., J. A. Malko et al., “Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report,” American Journal of Neuroradiology, vol. 8, no. 5, pp. 817–823, 1987.
[8]  W. S. Bartynski and L. Lin, “Dynamic and conventional spin-echo MR of pituitary microlesions,” American Journal of Neuroradiology, vol. 18, no. 5, pp. 965–972, 1997.
[9]  E. A. Sadowski, L. K. Bennett, M. R. Chan et al., “Nephrogenic systemic fibrosis: risk factors and incidence estimation,” Radiology, vol. 243, no. 1, pp. 148–157, 2007.
[10]  T. Stadnik, A. Stevenaert, A. Beckers, R. Luypaert, T. Buisseret, and M. Osteaux, “Pituitary microadenomas: diagnosis with two- and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium,” Radiology, vol. 176, no. 2, pp. 419–428, 1990.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133